Skip to main content

Table 1 Clinical characteristics of the groups with normal glucose tolerance and with prediabetes/type 2 diabetes

From: The relationships between FLAIS, a novel insulin sensitivity index, and cardiovascular risk factors in a population-based study

 

Normal glucose tolerance (n = 155)

Prediabetes/diabetes (n = 184)

Age (years)

42.33 ± 14.23

51.61 ± 14.19*

Sex (M/F)

50/105

96/88*

Systolic BP (mmHg)

117.42 ± 14.42

128.88 ± 18.14*

Diastolic BP (mmHg)

78.91 ± 8.88

83.96 ± 11.17*

BMI (kg/m2)

24.79 ± 4.14

27.96 ± 4.59*

Waist circumference (cm)

81.12 ± 11.25

91.06 ± 12.96*

Fasting plasma glucose (mg/dL)

93.24 ± 4.53

106.16 ± 10.38*

Post-OGTT plasma glucose (mg/dL)

107.29 ± 18.92

141.25 ± 41.93*

Fasting serum insulin (μIU/mL)

9.71 ± 5.03

14.49 ± 9.19*

Post-OGTT serum insulin (μIU/mL)

43.13 ± 28.42

82.92 ± 91.91*

Cholesterol (mg/dL)

182.36 ± 37.64

190.34 ± 38.14

Triglycerides (mg/dL)

96.28 ± 60.19

118.01 ± 72.89*

HDL-cholesterol (mg/dL)

63.05 ± 16.60

58.93 ± 14.17*

LDL-cholesterol (mg/dL)

117.84 ± 32.37

127.10 ± 35.76*

HOMA-IR

2.25 ± 1.20

3.88 ± 2.82*

QUICKI

0.35 ± 0.02

0.32 ± 0.03*

Matsuda index

6.21 ± 2.71

3.81 ± 2.28*

RBC (mln/μL)

4.71 ± 0.46

4.83 ± 0.40*

AlAt (U/L)

19.89 ± 11.67

25.06 ± 14.83*

C-peptide (pmol/mL)

0.71 ± 0.22

0.92 ± 0.38*

SHBG (nmol/L)

38.55 ± 25.79

30.44 ± 17.92*

Adiponectin (μg/mL)

16.18 ± 9.29

10.05 ± 7.29*

IGFBP-1 (ng/mL)

3.18 ± 2.70

2.12 ± 1.72*

FLAIS

7.74 ± 1.59

6.64 ± 1.41*

  1. *p < 0.05 vs normal glucose tolerance